111 related articles for article (PubMed ID: 38774936)
1. Epidemiological, Diagnostic and Therapeutic Aspects of Hepatocellular Carcinoma in Morocco: A Case Series and Review of Literature.
Zouaki I; Aiterrami A; Samlani Z; Oubaha S; Krati K
Gulf J Oncolog; 2024 May; 1(45):75-90. PubMed ID: 38774936
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma in Senegal: epidemiological, clinical and etiological aspects about 229 cases at
Diallo I; Ndiaye B; Touré M; Sow A; Mbengue A; Diawara PS; Gning SB; Mbaye PS; Fall F; Mbengue M
Pan Afr Med J; 2021; 38():99. PubMed ID: 33889265
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiological, clinical and therapeutic features of hepatocellular carcinoma in cirrhotic patients].
Said Y; Debbeche R; Ben Ali Z; Bouzid K; Trabelsi S; Bouzaidi S; Salem M; Rajhi H; Kouni Chahed M; Najjar T
Tunis Med; 2012 Jun; 90(6):468-72. PubMed ID: 22693088
[TBL] [Abstract][Full Text] [Related]
4. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.
Kubicka S; Rudolph KL; Hanke M; Tietze MK; Tillmann HL; Trautwein C; Manns M
Liver; 2000 Jul; 20(4):312-8. PubMed ID: 10959810
[TBL] [Abstract][Full Text] [Related]
6. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
[TBL] [Abstract][Full Text] [Related]
7. Profile of hepatocellular carcinoma in a tertiary care hospital in Punjab in northern India.
Sood A; Midha V; Goyal O; Goyal P; Sood N; Sharma SK
Indian J Gastroenterol; 2014 Jan; 33(1):35-40. PubMed ID: 24222369
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, clinical-treatment patterns and outcome in 256 hepatocellular carcinoma cases.
Fenoglio L; Serraino C; Castagna E; Cardellicchio A; Pomero F; Grosso M; Senore C
World J Gastroenterol; 2013 Jun; 19(21):3207-16. PubMed ID: 23745022
[TBL] [Abstract][Full Text] [Related]
9. Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era.
Waziry R; Gomaa A; Waked I; Dore GJ
Arab J Gastroenterol; 2018 Mar; 19(1):26-32. PubMed ID: 29506913
[TBL] [Abstract][Full Text] [Related]
10. [Hepatocellular carcinoma. Experience at the Instituto Nacional de Cancerología].
Mondragón Sánchez R; Ochoa Carrillo FJ; Ruiz Molina JM; Herrera Goepfer R; Oñate Ocaña LF; Aiello Crocifoglio V
Rev Gastroenterol Mex; 1997; 62(1):34-40. PubMed ID: 9190651
[TBL] [Abstract][Full Text] [Related]
11. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
[TBL] [Abstract][Full Text] [Related]
12. A new prognostic score can predict survival after hepatocellular carcinoma treatment in a cohort of 1302 Egyptian hepatocellular carcinoma patients.
Abdelaziz AO; Shousha HI; Abdelmaksoud AH; Saad Y; Elbaz TM; Soliman ZA; Salah A; Lithy R; Ahmed M; Nabil MM
Eur J Gastroenterol Hepatol; 2018 May; 30(5):514-519. PubMed ID: 29465472
[TBL] [Abstract][Full Text] [Related]
13. Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015.
Kim NG; Nguyen PP; Dang H; Kumari R; Garcia G; Esquivel CO; Nguyen MH
Cancer; 2018 Jun; 124(12):2588-2598. PubMed ID: 29624631
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.
Ungtrakul T; Mahidol C; Chun-On P; Laohapand C; Siripongsakun S; Worakitsitisatorn A; Vidhayakorn S; Boonchuay W; Dechma J; Sornsamdang G; Soonklang K; Sriprayoon T; Tanwandee T; Auewarakul CU
World J Gastroenterol; 2016 Sep; 22(34):7806-12. PubMed ID: 27678364
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and management of hepatocellular carcinoma.
Yang JD; Roberts LR
Infect Dis Clin North Am; 2010 Dec; 24(4):899-919, viii. PubMed ID: 20937457
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics, staging and treatment of patients with hepatocellular carcinoma in clinical practice. Prospective study of 136 patients].
Gómez Rodríguez R; Romero Gutiérrez M; González de Frutos C; de Artaza Varasa T; de la Cruz Perez G; Ciampi Dopazo JJ; Lanciego Pérez C; Gómez Moreno AZ
Gastroenterol Hepatol; 2011 Oct; 34(8):524-31. PubMed ID: 21940068
[TBL] [Abstract][Full Text] [Related]
17. [Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic].
Petry W; Heintges T; Hensel F; Erhardt A; Wenning M; Niederau C; Häussinger D
Z Gastroenterol; 1997 Dec; 35(12):1059-67. PubMed ID: 9487638
[TBL] [Abstract][Full Text] [Related]
18. Risk factors of mortality in the patients with hepatocellular carcinoma: A multicenter study in Indonesia.
Jasirwan COM; Hasan I; Sulaiman AS; Lesmana CRA; Kurniawan J; Kalista KF; Nababan SH; Gani RA
Curr Probl Cancer; 2020 Feb; 44(1):100480. PubMed ID: 31130257
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapy.
Eskens FA; van Erpecum KJ; de Jong KP; van Delden OM; Klumpen HJ; Verhoef C; Jansen PL; van den Bosch MA; Méndez Romero A; Verheij J; Bloemena E; de Man RA
Neth J Med; 2014 Jul; 72(6):299-304. PubMed ID: 25319854
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma from the view of gastroenterologist/hepatologist.
Petr U; Petr H
Klin Onkol; 2020; 33(Supplementum 3):34-44. PubMed ID: 33213164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]